I received his M.S. and Ph.D. in Pharmaceutical Sciences from St. John’s University (Queens, NY) in 2013 and 2016, respectively. From 2011-2016,I worked as a Graduate Student Researcher at St. John’s University, where he also served as a Graduate Teaching Assistant from 2013-2015 and a Doctoral Teaching Fellow from 2015-2016. Since 2016, Dr. Wang has served as a Postdoctoral Associate at the University of Pittsburgh Cancer Institute, where I am continuing to conduct stellar work that is influencing scholars across the globe. I have reviewed for 15 different scholarly journals, including distinguished outlets such as Scientific Reports, Biochemical Pharmacology, Oncotarget, and Molecular Carcinogenesis. Only the top researchers in their fields of study are selected by journals to participate in peer review, and prestigious journals like these four are unusually selective. Moreover, I also sits on the editorial board for the Journal of Cancer Research Updates, Austin Pharmacology & Pharmaceutics, and the Pharmaceutical Sciences and Biomedical Analysis Journal.

Yi-Jun Wang Research Interests are Investigating the role of different forms of cell death, including apoptosis, necropoptosis, immunogenic cell death, in cancer pharmacology, targeted cancer therapy, and immunotherapy.Conducted in vitro and in vivo research on the molecular and cellular pharmacology of anticancer drugs, such as the multidrug resistance (MDR) mechanisms, the reversal study of drug resistance and the new anticancer drug development.